Rowe D T, Clarke J R
Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London, U.K.
J Gen Virol. 1989 May;70 ( Pt 5):1217-29. doi: 10.1099/0022-1317-70-5-1217.
The Epstein-Barr virus nuclear antigen 2 (EBNA 2) shows serotype variation and two serologically distinct groups of viruses have been identified. These correspond to the two hybridization groups of viruses (A and B) that are distinguished by a highly substituted nucleic acid sequence in the middle of the open reading frame of the EBNA 2 gene. An epitope survey of the EBNA 2-coding region was carried out using a new prokaryotic expression vector tailored to express DNA fragments from the M13 sequencing libraries of the B95-8 (type A) and Jijoye (type B) prototype virus strains. Short overlapping stretches of EBNA 2 sequence were expressed as fusion proteins and used in Western blotting with human sera that contained serotype-specific antibodies. The type A-specific epitope was located between residues 378 and 435 of the B95-8 EBNA 2 polypeptide and the type B-specific epitope mapped between residues 390 and 454, at the carboxy terminus of the Jijoye polypeptide chain. All of the type-specific anti-EBNA 2 sera tested reacted with fusion proteins containing one or other of these epitopes. Despite the direct correlation between the hybridization and serological phenotypes, the type-specific epitopes appear to lie in the relatively conserved carboxy-terminal region of EBNA 2. There was no indication that the residues of the non-homologous region contributed to the formation of antibody-combining sites.
爱泼斯坦-巴尔病毒核抗原2(EBNA 2)存在血清型变异,已鉴定出两组血清学上不同的病毒。这两组病毒分别对应病毒的两个杂交组(A组和B组),它们通过EBNA 2基因开放阅读框中间高度取代的核酸序列来区分。利用一种新的原核表达载体对EBNA 2编码区进行了表位研究,该载体专门用于表达来自B95-8(A 型)和Jijoye(B型)原型病毒株M13测序文库的DNA片段。EBNA 2序列的短重叠片段被表达为融合蛋白,并用于与含有血清型特异性抗体的人血清进行蛋白质印迹分析。A型特异性表位位于B95-8 EBNA 2多肽的378至435位氨基酸残基之间,B型特异性表位位于Jijoye多肽链羧基末端的390至454位氨基酸残基之间。所有测试的型特异性抗EBNA 2血清都与含有这些表位之一的融合蛋白发生反应。尽管杂交表型与血清学表型之间存在直接关联,但型特异性表位似乎位于EBNA 2相对保守的羧基末端区域。没有迹象表明非同源区域的氨基酸残基有助于抗体结合位点的形成。